COMBINATION THERAPY USING A BETA 3 ADRENERGIC RECEPTOR AGONIST AND AN ANTIMUSCARINIC AGENT

• 收藏
• 分享

专利权人:

MERCK SHARP & DOHME CORP

发明人:

申请号：

IL21875612

公开号：

IL218756D0

申请日:

2012.03.20

申请国别(地区):

IL

年份:

2012

代理人:

摘要：

Described herein is an improved method of treating overactive bladder, wherein the method comprises administering to a patient in need thereof a beta 3 adrenergic receptor agonist, an antimuscarinic agent, and an optional selective M2 antagonist. Such combination therapy provides improved efficacy and/or reduced side effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/